Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 2
2002 1
2003 4
2004 3
2005 1
2006 2
2008 2
2009 1
2011 1
2012 4
2013 2
2014 3
2015 4
2016 3
2017 2
2018 2
2019 6
2020 8
2021 8
2022 6
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Lendvai N, Sborov D, Suvannasankha A, Weisel K, Karlin L, Libby E, Arnulf B, Facon T, Hulin C, Kortüm KM, Rodríguez-Otero P, Usmani SZ, Hari P, Baz R, Quach H, Moreau P, Voorhees PM, Gupta I, Hoos A, Zhi E, Baron J, Piontek T, Lewis E, Jewell RC, Dettman EJ, Popat R, Esposti SD, Opalinska J, Richardson P, Cohen AD. Lonial S, et al. Among authors: piontek t. Lancet Oncol. 2020 Feb;21(2):207-221. doi: 10.1016/S1470-2045(19)30788-0. Epub 2019 Dec 16. Lancet Oncol. 2020. PMID: 31859245 Clinical Trial.
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Sborov D, Suvannasankha A, Weisel K, Voorhees PM, Womersley L, Baron J, Piontek T, Lewis E, Opalinska J, Gupta I, Cohen AD. Lonial S, et al. Among authors: piontek t. Cancer. 2021 Nov 15;127(22):4198-4212. doi: 10.1002/cncr.33809. Epub 2021 Jul 27. Cancer. 2021. PMID: 34314018 Free PMC article. Clinical Trial.
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
Farooq AV, Degli Esposti S, Popat R, Thulasi P, Lonial S, Nooka AK, Jakubowiak A, Sborov D, Zaugg BE, Badros AZ, Jeng BH, Callander NS, Opalinska J, Baron J, Piontek T, Byrne J, Gupta I, Colby K. Farooq AV, et al. Among authors: piontek t. Ophthalmol Ther. 2020 Dec;9(4):889-911. doi: 10.1007/s40123-020-00280-8. Epub 2020 Jul 25. Ophthalmol Ther. 2020. PMID: 32712806 Free PMC article.
Letter to the editor.
Bąkowski P, Piontek T. Bąkowski P, et al. Among authors: piontek t. Knee Surg Sports Traumatol Arthrosc. 2022 Dec;30(12):4258-4259. doi: 10.1007/s00167-022-07178-x. Epub 2022 Oct 7. Knee Surg Sports Traumatol Arthrosc. 2022. PMID: 36207459 Free PMC article. No abstract available.
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
Lonial S, Nooka AK, Thulasi P, Badros AZ, Jeng BH, Callander NS, Potter HA, Sborov D, Zaugg BE, Popat R, Degli Esposti S, Byrne J, Opalinska J, Baron J, Piontek T, Gupta I, Dana R, Farooq AV, Colby K, Jakubowiak A. Lonial S, et al. Among authors: piontek t. Blood Cancer J. 2021 May 26;11(5):103. doi: 10.1038/s41408-021-00494-4. Blood Cancer J. 2021. PMID: 34039952 Free PMC article. Clinical Trial.
Correction to: Letter to the editor.
Bąkowski P, Piontek T. Bąkowski P, et al. Among authors: piontek t. Knee Surg Sports Traumatol Arthrosc. 2022 Dec 1. doi: 10.1007/s00167-022-07244-4. Online ahead of print. Knee Surg Sports Traumatol Arthrosc. 2022. PMID: 36454295 No abstract available.
VECMAtk: a scalable verification, validation and uncertainty quantification toolkit for scientific simulations.
Groen D, Arabnejad H, Jancauskas V, Edeling WN, Jansson F, Richardson RA, Lakhlili J, Veen L, Bosak B, Kopta P, Wright DW, Monnier N, Karlshoefer P, Suleimenova D, Sinclair R, Vassaux M, Nikishova A, Bieniek M, Luk OO, Kulczewski M, Raffin E, Crommelin D, Hoenen O, Coster DP, Piontek T, Coveney PV. Groen D, et al. Among authors: piontek t. Philos Trans A Math Phys Eng Sci. 2021 May 17;379(2197):20200221. doi: 10.1098/rsta.2020.0221. Epub 2021 Mar 29. Philos Trans A Math Phys Eng Sci. 2021. PMID: 33775151 Free PMC article.
Predicting queue wait time probabilities for multi-scale computing.
Jancauskas V, Piontek T, Kopta P, Bosak B. Jancauskas V, et al. Among authors: piontek t. Philos Trans A Math Phys Eng Sci. 2019 Apr 8;377(2142):20180151. doi: 10.1098/rsta.2018.0151. Philos Trans A Math Phys Eng Sci. 2019. PMID: 30967035 Free PMC article.
58 results